Michael Buscher, DO, FCCM
Bridgeport Hospital Yale-New Haven Health System
Disclosure(s): No relevant financial relationship(s) to disclose.
Patrick Maher, MD (he/him/his)
Icahn School of Medicine at Mount Sinai, California
Disclosure(s): Werfen: Scientific Advisory Board (Ongoing)
Caitlin Brown, BCCCP, PharmD, FCCM (she/her/hers)
Mayo Clinic, Minnesota
Disclosure(s): Astra Zeneca: Consultant (Terminated, October 31, 2024); Wolters Kluwer: Consultant (Ongoing)
This high-energy session will dive into the hottest debates shaping rapid sequence intubation practice today. Should ketamine replace etomidate in septic patients, despite its potential hemodynamic pitfalls? Is cricoid pressure a protective safeguard or a dangerous relic that hinders laryngoscopy and ventilation? Join us as we cut through the noise, challenge dogma, and explore how evolving science should reshape your approach to one of our most high-stakes procedures.
